BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23557655)

  • 1. Systemic treatments for severe pediatric psoriasis: a practical approach.
    Marqueling AL; Cordoro KM
    Dermatol Clin; 2013 Apr; 31(2):267-88. PubMed ID: 23557655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe psoriasis in children: recommendations of an Italian expert group.
    Fortina AB; Bardazzi F; Berti S; Carnevale C; Di Lernia V; El Hachem M; Neri I; Gelmetti CM; Lora V; Mazzatenta C; Milioto M; Moretta G; Patrizi A; Peris K; Villani A
    Eur J Pediatr; 2017 Oct; 176(10):1339-1354. PubMed ID: 28836064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's new in the management of psoriasis?
    Kinney MA; Feldman SR
    G Ital Dermatol Venereol; 2009 Apr; 144(2):103-17. PubMed ID: 19357619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on pediatric psoriasis, Part 2: Therapeutic management.
    Silverberg NB
    Cutis; 2010 Oct; 86(4):172-6. PubMed ID: 21140923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic combination treatment for psoriasis: a review.
    Jensen P; Skov L; Zachariae C
    Acta Derm Venereol; 2010 Jul; 90(4):341-9. PubMed ID: 20574597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of 308nm laser treatment of psoriasis compared to historical controls.
    Rodewald EJ; Housman TS; Mellen BG; Feldman SR
    Dermatol Online J; 2001 Dec; 7(2):4. PubMed ID: 12165220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
    Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
    Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.
    Carpentieri A; Pacello L; De Marco IM; Loiacono A; Picconi O; Loconsole F
    J Dermatolog Treat; 2016 Oct; 27(5):399-405. PubMed ID: 26822691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and light therapies for the management of childhood psoriasis: part II.
    Cordoro KM
    Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of treatment modalities for psoriasis.
    Tristani-Firouzi P; Krueger GG
    Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Psoriasis.
    Smith J; Cline A; Feldman SR
    South Med J; 2017 Jan; 110(1):65-75. PubMed ID: 28052180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic therapy of psoriasis].
    Altmeyer P; Nüchel C
    Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
    Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
    J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatments in childhood psoriasis: a French multicentre study on 154 children.
    Charbit L; Mahé E; Phan A; Chiaverini C; Boralevi F; Bourrat E; Lasek A; Maruani A; Aubin F; Droitcourt C; Barbarot S; Mallet S; Mazereeuw-Hautier J; Begon E; Abasq C; Plantin P; Souillet AL; Hadj-Rabia S; Bursztejn AC;
    Br J Dermatol; 2016 May; 174(5):1118-21. PubMed ID: 26617180
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of biologic agents in pediatric psoriasis.
    Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
    J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of inflammatory nail disorders.
    Dehesa L; Tosti A
    Dermatol Ther; 2012; 25(6):525-34. PubMed ID: 23210751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis.
    Burfield L; Burden AD
    J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.